AOBI (American Oriental Bioengineering) LT-Debt-to-Total-Asset : 0.01 (As of Sep. 2013)

View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. American Oriental Bioengineering's long-term debt to total assests ratio for the quarter that ended in Sep. 2013 was 0.01.

American Oriental Bioengineering's long-term debt to total assets ratio increased from Sep. 2012 (0.00) to Sep. 2013 (0.01). It may suggest that American Oriental Bioengineering is progressively becoming more dependent on debt to grow their business.

American Oriental Bioengineering LT-Debt-to-Total-Asset Historical Data

The historical data trend for American Oriental Bioengineering's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering LT-Debt-to-Total-Asset Chart

American Oriental Bioengineering Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.22

0.20

0.19

American Oriental Bioengineering Quarterly Data
	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	0.01

American Oriental Bioengineering LT-Debt-to-Total-Asset Calculation

American Oriental Bioengineering's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2012 is calculated as

LT Debt to Total Assets (A: Dec. 2012 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2012 )	/	Total Assets (A: Dec. 2012 )
	=	0.555	/	446.309
	=	0.00

American Oriental Bioengineering's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2013 is calculated as

LT Debt to Total Assets (Q: Sep. 2013 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2013 )	/	Total Assets (Q: Sep. 2013 )
	=	5.057	/	427.625
	=	0.01

American Oriental Bioengineering (OTCPK:AOBI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

American Oriental Bioengineering LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oriental Bioengineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176

Website

https://www.bioaobo.com

American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.

Executives

Patti Cosimo J

director

AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering Headlines

No Headlines